stars 1 stars 2 stars 3

Neuron23 Inc. is a clinical-stage biotechnology company focused on developing precision medicines for Parkinson’s disease driven by hyperactive LRRK2. Neuron23 combines advances in human genetics with a state-of-the-art drug discovery and biomarker platform, leveraging advanced techniques in machine learning and artificial intelligence to advance therapeutics aimed at impacting disease progression. The company’s focus is on transforming the future of treatment for PD through innovation, collaboration, and dedication to enhancing patient outcomes. Founded in 2018, Neuron23 has assembled a world-class team of experts and entrepreneurs located in South San Francisco, CA.

Neuron23 Questions

Arash Rassoulpour is the COO of Neuron23.

34 people are employed at Neuron23.

Neuron23 is based in South San Francisco, California.

Top Neuron23 Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Winter 2026 G2 Leader Mid Market Winter 2026 G2 Leader Small Business Winter 2026 G2 Most Implementable Winter 2026 G2 Best Est ROI Mid Market Winter 2026 G2 Leader Momentum Winter 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2025
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users